Alliance Researchers to Identify Biomarkers to Predict Brain Metastatic Behavior in Patients with Non-small Cell Lung Cancer

Alliance researchers at Washington University School of Medicine and the Siteman Cancer Center have been awarded $1.47 million to study whether a tumor’s DNA sequence can predict brain metastasis in patients with non-small cell lung cancer (NSCLC). Mark Watson, MD, PhD, Associate Professor of Pathology and Immunology, and Ramaswamy Govindan, MD, Professor of Medicine, received the five-year grant from the National Cancer Institute (NCI). They intend to use a tumor’s DNA sequence i


UPCOMING MEETINGS

2015 Spring Group Meeting | May 13-16 | Schedule | Register
2015 Fall Group Meeting | November 4-8
2016 Fall Group Meeting | November 2-5
2017 Fall Group Meeting | November 1-4

Loews Hotel Chicago O'Hare, Rosemont, IL 60018
open to all Alliance members

TWEETS

FROM THE NCI

RSS Feed Widget